Literature DB >> 35784947

Oxidative stress in the retina: implications for Retinopathy of Prematurity.

Xanthi I Couroucli1.   

Abstract

Oxygen supplementation has been used as a part of respiratory care for preterm and term newborns since the beginning of 19th century. Although oxygen administration can be life-saving, reactive oxygen species (ROS) and reactive nitrogen species (RNS) due to hyperoxia can have detrimental effects in the developing organs of the preterm infants, with both short and long term consequences. Oxygen toxicity on the immature tissues of preterm infants can contribute to the development of several diseases like retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD). The vascular development of human retina is completed at term, whereas the neural retina develops up to 5 years of age. Disruption of the normal retinal neurovascular growth is the pathognomonic feature of ROP, and can lead to vision threatening disease or even blindness. It is estimated that at least 100,000 infants all over the world will be blind every year due to ROP, which is the leading cause of blindness in children. In this review we will discuss the role of ROS and RNS in the development of ROP, and how through historical, epidemiological, and developmental aspects of this devastating disease, we can design future research for its prevention and treatment.

Entities:  

Keywords:  RNS; ROP; ROS; VEGF; hyperoxia; preterm infant; retina

Year:  2017        PMID: 35784947      PMCID: PMC9245835          DOI: 10.1016/j.cotox.2017.11.008

Source DB:  PubMed          Journal:  Curr Opin Toxicol        ISSN: 2468-2020


  76 in total

1.  Childhood blindness in the context of VISION 2020--the right to sight.

Authors:  C Gilbert; A Foster
Journal:  Bull World Health Organ       Date:  2003-07-07       Impact factor: 9.408

2.  A Proposal for a New Method of Evaluation of the Newborn Infant. Originally published in July 1953, volume 32, pages 250-259.

Authors:  Virginia Apgar
Journal:  Anesth Analg       Date:  2015-05       Impact factor: 5.108

3.  Angiogenesis and Eye Disease.

Authors:  Yoshihiko Usui; Peter D Westenskow; Salome Murinello; Michael I Dorrell; Lea Scheppke; Felicitas Bucher; Susumu Sakimoto; Liliana P Paris; Edith Aguilar; Martin Friedlander
Journal:  Annu Rev Vis Sci       Date:  2015-11-24       Impact factor: 6.422

4.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

Authors:  Helen A Mintz-Hittner; Kathleen A Kennedy; Alice Z Chuang
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

Review 5.  Oxidative Stress Related Diseases in Newborns.

Authors:  Yasemin Ozsurekci; Kubra Aykac
Journal:  Oxid Med Cell Longev       Date:  2016-06-15       Impact factor: 6.543

Review 6.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

7.  Multifocal ERG Responses in Subjects With a History of Preterm Birth.

Authors:  Pablo Altschwager; Anne Moskowitz; Anne B Fulton; Ronald M Hansen
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

Review 8.  Promoting vascular repair in the retina: can stem/progenitor cells help?

Authors:  Thao Le Phuong Trinh; Sergio Li Calzi; Lynn C Shaw; Mervin C Yoder; Maria B Grant
Journal:  Eye Brain       Date:  2016-05-26

Review 9.  Optical coherence tomography of the preterm eye: from retinopathy of prematurity to brain development.

Authors:  Adam L Rothman; Shwetha Mangalesh; Xi Chen; Cynthia A Toth
Journal:  Eye Brain       Date:  2016-05-27

Review 10.  Retinal, visual, and refractive development in retinopathy of prematurity.

Authors:  Anne Moskowitz; Ronald M Hansen; Anne B Fulton
Journal:  Eye Brain       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.